Cardiovascular Risk Intervention Study to Optimise Treatment in Patients with Hypertension
| ISRCTN | ISRCTN44478543 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN44478543 |
| Secondary identifying numbers | 01GL0501 |
- Submission date
- 15/02/2006
- Registration date
- 12/06/2006
- Last edited
- 08/05/2015
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Prof Heinz-Harald Abholz
Scientific
Scientific
Abteilung für Allgemeinmedizin
Universitätsklinik
Moorenstr. 5
Düsseldorf
40225
Germany
| Phone | +49 (0)211 8117771 |
|---|---|
| abholz@med.uni-duesseldorf.de |
Study information
| Study design | Cluster-randomised controlled two-arm interventional study |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Cluster randomised trial |
| Study setting(s) | GP practice |
| Study type | Treatment |
| Scientific title | Cardiovascular Risk Intervention Study to Optimise Treatment in Patients with Hypertension |
| Study acronym | CRISTOPH |
| Study objectives | As of 21/07/2008, the following amendments have been made to this ISRCTN record: 1. The end date of this trial was updated from 31/01/2007 to 31/12/2007. This reflects a delay to this trial due to several factors, mostly related to data collection 2. An amendment has been made to the Primary outcome measures field, as some errors were found in the information provided at time of registration Hypothesis: Absolute cardiovascular risk (CVR), calculated using the SCORE-formula (Conroy et al., European Heart Journal 2003; http://www.ncbi.nlm.nih.gov/pubmed/12788299), can be significantly decreased in patients with high CVR by means of a composed intervention, targeted at general practitioners, of posting specifically adapted guidelines and two educational outreach peer-visits (group A), compared with posting adapted guidelines alone (group B = control). An embedded qualitative study (semi-structured interviews with general practitioners) focuses on the main reasons for physicians' non-compliance with guidelines in the German context. |
| Ethics approval(s) | Ethics Committee of the Medical Faculty, University of Düsseldorf, 02/12/2005, ref: 2715 |
| Health condition(s) or problem(s) studied | Increased cardiovascular risk |
| Intervention | This is a cluster-randomised controlled two-arm interventional study with an embedded qualitative study. A cluster is composed of the recruited patients of one GP surgery; in group practices, all GP partners are allocated to the same study arm. Both groups A and B (the control arm) will receive specifically composed information by post, based on current guidelines on cardiovascular disease prevention. In addition, group A will receive two educational outreach peer-visits, directed at a deeper appreciation of the concept of treating patients according to individual absolute cardiovascular risk. |
| Intervention type | Other |
| Primary outcome measure | Current primary outcome measures as of 21/07/2008: Primary endpoint is the mean absolute cardiovascular risk (CVR) of the subset of patients with high CVR (but no manifest cardiovascular disease) in each randomisation group (A versus B). The composite endpoint 'cardiovascular risk' is calculated from several risk factors by using a slightly modified version of the SCORE formula published by Conroy et al. (European Heart Journal 2003). Previous primary outcome measures: Primary endpoint is the mean absolute cardiovascular risk (CVR) of the patients in each group. The composed endpoint cardiovascular risk is calculated from the single given risk factors by using a slightly modified version of the SCORE-formula published by Conroy et al. (European Heart Journal 2003). For the qualitative study: adapting existing guideline tools for physicians' compliance. |
| Secondary outcome measures | 1. The intervention's effect on blood pressure, cholesterol levels, smoking rates, and physical exercise in patients with: a. A history of manifested CV disease b. High CVR (defined by SCORE >4%) c. Low CVR (SCORE <5%) 2. The intervention's effect on drug treatment, judged by current guidelines, in patients with: a. A history of manifested CV disease b. High CVR c. Low CVR 3. A possible relationship of CVR with: a. Patient gender b. Patients' socioeconomic status c. The quality of the doctor-patient-relationship 4. The intervention's effect on: a. The accuracy with which doctors and patients estimate individual CVR b. The degree to which the patient is being involved in the decision making process |
| Overall study start date | 01/03/2006 |
| Completion date | 31/12/2007 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | Both |
| Target number of participants | 102 GPs, 4080 patients; interviews: 30 additional GPs |
| Key inclusion criteria | 102 general practitioners will be recruited to participate in the study, and will be randomised into groups A or B. Each GP recruits a consecutive sample of 40 patients meeting the following criteria: 1. Aged 40-75 years 2. Known diagnosis of hypertension for >6 months 3. Life expectancy not <1 year 4. Fluency in the German language The sample for the qualitative part covers 30 general practitioners not belonging to the quantitative study sample within the same region before the study and 15 general practitioners within the RCT-sample after the quantitative study. |
| Key exclusion criteria | Exclusion criteria for GPs are: 1. Less than 500 cases per three months (quarter) 2. Atypical patients or practice Exclusion criteria for patients: see inclusion criteria |
| Date of first enrolment | 01/03/2006 |
| Date of final enrolment | 31/12/2007 |
Locations
Countries of recruitment
- Germany
Study participating centre
Abteilung für Allgemeinmedizin
Düsseldorf
40225
Germany
40225
Germany
Sponsor information
German Federal Ministry of Education and Research (BMBF) and the Federation of Sickness Fund Boards
Government
Government
c/o Projektträger im DLR
Heinrich-Konen-Str. 1
Bonn
53227
Germany
| Phone | +49 (0)228 38210 |
|---|---|
| claudia.ritter@dlr.de | |
| Website | http://www.pt-dlr.de |
"ROR" |
https://ror.org/04pz7b180 |
Funders
Funder type
Government
German Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung [BMBF])
No information available
Federation of Sickness Fund Boards (Spitzenverbände der Gesetzlichen Krankenkassen)
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Protocol article | protocol | 10/06/2008 | Yes | No | |
| Results article | results | 07/05/2015 | Yes | No |
